Pharmacoresistant epilepsy: if at first you don't succeed…

cytic choriomeningitis. Medicine 1942;21:1–63. 6. Chesney PJ, Katcher ML, Nelson DB, Horowitz SD. CSF eosinophilia and chronic lymphocytic choriomeningitis virus meningitis. J Pediatr 1979;94:750–752. 7. Jamieson DG, Mehta PD, Lavi E. Oligoclonal immunoglobulin bands in cerebrospinal fluid of a patient with lymphocytic choriomeningitis. Ann Neurol 1986;19:386–388. 8. Adair CV, Gould RL, Smadel JF. Aseptic meningitis, a disease of diverse etiology: clinical and etiologic studies on 854 cases. Ann Intern Med 1953;39:675–704. 9. Lewis JM, Utz JP. Orchitis, parotitis and meningoencephalitis due to lymphocytic choriomeningitis virus. N Engl J Med 1961;265:776–780. 10. Schanen A, Gallou G, Hincky J-M, Saron M-F. A rash, circulating anticoagulant, then meningitis. Lancet 1998;351: 1856. 11. Burnet FM. A modification of Jerne’s theory of antibody production using the concept of clonal selection. Aust J Sci 1957; 20:67–69. 12. Oldstone MBA, Dixon FJ. Pathogenesis of chronic disease associated with persistent lymphocytic choriomeningitis viral infection. I. Relationship of antibody production to disease in neonatally infected mice. J Exp Med 1969;129: 483– 499. 13. Camenga DL, Walker DH, Murphy FA. Anticonvulsant prolongation of survival in adult murine lymphocytic choriomeningitis. I. Drug treatment and virologic studies. J Neuropathol Exp Neurol 1977;36:9–20. 14. Rowe WP. Protective effect of pre-irradiation on lymphocytic choriomeningitis infection in mice. Proc Soc Exp Biol 1956;92: 194–198. 15. Gilden DH, Cole GA, Monjan AA, Nathanson N. Immunopathogenesis of acute central nervous system disease produced by lymphocytic choriomeningitis virus. I. Cyclophosphamidemediated induction of the virus-carrier state in adult mice. J Exp Med 1972;135:860–873. 16. Gilden DH, Cole GA, Nathanson N. Immunopathogenesis of acute central nervous system disease produced by lymphocytic choriomeningitis virus. II. Adoptive immunization of virus carriers. J Exp Med 1972;135:874–889. 17. Zinkernagel RM, Doherty PC. Restriction of in vitro T cellmediated cytotoxicity in lymphocytic choriomeningitis with a syngeneic or semiallogeneic system. Nature 1974;248: 701–702. 18. Monjan AA, Gilden DH, Cole GA, Nathanson N. Cerebellar hypoplasia in neonatal rats caused by lymphocytic choriomeningitis virus. Science 1971;171:194–196. 19. Monjan AA, Cole GA, Nathanson N. Pathogenesis of cerebellar hypoplasia produced by lymphocytic choriomeningitis virus infection of neonatal rats: protective effect of immunosuppression with antilymphoid serum. Infect Immun 1974;10: 499 –502. 20. Gilden DH, Friedman HM, Nathanson N. Tamiami virusinduced cerebellar heterotopia. J Neuropathol Exp Neurol 1974:33:29–41. 21. Friedman HM, Gilden DH, Roosa RA, Nathanson N. The effect of neonatal thymectomy on Tamiami virus-induced central nervous system disease. J Neuropathol Exp Neurol 1975;34: 159–166. 22. Kagi D, Ledermann B, Burki K, et al. Cytotoxicity mediated by T cell and natural killer cells is greatly impaired in perforindeficient mice. Nature 1994;369:31–37. 23. Guidotti LG, Rochford R, Chung J, et al. Viral clearance without destruction of infected cells during active HBV infection. Science 1999;284:825–830. 24. Moriyama T, Guilhot S, Klopchin K, et al. Immunobiology and pathogenesis of hepatocellular injury in hepatitis B virus transgenic mice. Science 1990;248:361–364. 25. Sheinbergas MM. Antibody to lymphocytic choriomeningitis virus in children with congenital hydrocephalus. Acta Virol 1975;19:165–166. 26. Bonthius DJ, Wright R, Tseng B, et al. Congenital lymphocytic choriomeningitis virus infection: spectrum of disease. Ann Neurol 2007;62:347–355. 27. Bonthius DJ, Nichols B, Harp H, et al. Lymphocytic choriomeningitis virus infection of the developing brain: critical role of host age. Ann Neurol 2007;62:356–374. 28. Monjan AA, Cole GA, Gilden DH, Nathanson N. Pathogenesis of cerebellar hypoplasia produced by lymphocytic choriomeningitis virus infection of neonatal rats. I. Evolution of disease following infection at 4 days of age. J Neuropathol Exp Neurol 1973;32:110–124.